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Human embryos donated for embryonic stem cell (ESC) derivation have often been cryopreserved for 5–10 years. As a consequence,
many of these embryos have been cultured in media now known to affect embryo viability and the number of ESC progenitor
epiblast cells. Historically, these conditions supported only low levels of blastocyst development necessitating their transfer or
cryopreservation at the 4–8-cell stage. As such, these embryos are donated at the cleavage stage and require further culture to
the blastocyst stage before hESC derivation can be attempted. These are generally of poor quality, and, consequently, the efficiency
of hESC derivation is low. Recent work using a mouse model has shown that the culture of embryos from the cleavage stage with
insulin to day 6 increases the blastocyst epiblast cell number, which in turn increases the number of pluripotent cells in outgrowths
following plating, and results in an increased capacity to give rise to ESCs. These findings suggest that culture with insulin may
provide a strategy to improve the efficiency with which hESCs are derived from embryos donated at the cleavage stage.
1. Introduction
Theembryo begins as a single totipotent cell it thenundergoes
multiple rounds of division coupled with differentiation until
it forms a blastocyst and has the potential to implant in
the uterus. The pluripotent epiblast of the inner cell mass
(ICM) then undergoes further division and differentiation
to develop into the fetus and eventually a fully developed
organism. Epiblast cells can be isolated and cultured in
conditions which allow embryonic stem cell (ESC) lines to
be derived. ESC lines, especially hESC lines, hold consider-
able promise in the fields of drug discovery, developmental
biology and regenerative medicine. However, the efficiency
of hESC derivation is low.This paper brings together work by
our group which used a mouse model to develop a strategy
for improving the efficiency of hESC derivation. As most
embryos donated for human ESC derivation were cultured in
relatively simple media, now known to perturb development,
before being frozen at the precompaction stage up to 10 years
earlier, we examined the hypothesis that the period where
they are subsequently cultured to the blastocyst stage could be
exploited to improve the efficiency with which cell lines could
be derived. In particular, our work has focussed on adding
insulin to culture media to increase epiblast cell number.
In initial studies [1], we showed that in vitro culture
of embryos during the precompaction stage in a simple
medium that was designed to model the culture conditions
that human embryos available for hESC derivation were pre-
viously exposed to reduces embryo quality; as highlighted by
reduced developmental rates, decreased epiblast cell number
and altered gene expression in outgrowths compared with
that seen for embryos culture in modern G1 medium. Some
aspects of this reduction in quality could be restored after
compaction by culture in a medium designed to support
postcompaction embryo development in vitro (G2), includ-
ing epiblast cell number. However, epiblast cell number was
only partially improved compared with embryos cultured in
G1/G2. The findings of [2, 3] as well as our own later studies
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[4] suggest that increased epiblast cell number correlates with
an increased capacity to give rise to ESCs. Culture in G2
medium postcompaction also increased the proportion of
embryos which reached the hatched blastocyst stage which
was subsequently shown in [4] to be correlated with an
increased capacity to give rise to primary ESC colonies.
Together, these findings highlight that subsequent culture in
modern culture systems can improve the efficiency of ESC
derivation from embryos initially cultured in simple media.
Numerous growth factors are known to influence embryo
development. However, these are not routinely included in
embryo culture media. In contrast, growth factors such as
leukaemia inhibitory factor (LIF) are routinely used for the
isolation and maintenance of ESCs. Based on these obser-
vations, we hypothesised that addition of a growth factor
to embryo culture media could further improve blastocyst
development, epiblast cell number, outgrowth formation rate,
and ESC derivation. In particular, we investigated whether
insulin could be used to increase ESC derivation efficiency
because it has previously been shown to increase ICM cell
number when added to embryo culture media [5, 6].
The results from these studies showed that the inclusion
of insulin in postcompaction culture medium increased the
number of pluripotent cells in blastocysts. In a series of
experiments we showed that insulin acted via the PI3K/GSK3
p53 pathway to shift the balance of differentiation versus
pluripotency within the ICM to increase epiblast number and
proportion [7]. This resulted in an increase in their capacity
to give rise to outgrowths with more pluripotent cells, as
well as an increase in capacity to give rise to primary ESC
colonies [4]. These findings suggest that the inclusion of
insulin in embryo culture medium postcompaction could be
used to improve the quality of cryopreserved or fresh human
embryos donated at or near compaction.
2. Impact of Culture Conditions on Epiblast
Cell Number and Pluripotency
The relatively low efficiency with which hESCs can be derived
has been attributed to the reduced quality of human embryos
donated for this purpose [8–10]. In vitro culture of embryos
is typically associated with reductions in embryo quality
and viability [11]. Furthermore, human embryos for hESC
derivation have often been cryopreserved for 5–10 years prior
to their donation [12, 13]. As a consequence many were
cultured in media now known to perturb viability, and which
supported only low levels of blastocyst development. This
necessitated cleavage stage transfers for the majority of IVF
cycles performed.
In order to model this system, mouse embryos were
cultured in relatively simple medium for the first 48 h to
the 8-cell stage to approximate the culture period commonly
used in human IVF experiments [1]. These experiments
demonstrated that culture of embryos in simple medium
retarded the development of blastocysts and significantly
reduced the number of epiblast cells, which was consistent
with previous studies in human and mouse [14–19]. These
experiments also demonstrated that there was some capacity
to improve blastocyst development and epiblast cell number
by transferring embryos to the more complex G2 medium
for culture from the 8-cell stage. Despite this, initial culture
in relatively simple medium had a lasting negative impact
on subsequent development. Furthermore, we found that
embryos cultured in simple medium were less likely to
contain an epiblast and therefore lacked the capacity to
generate an ESC line, irrespective of the culturemediumused
for the second 48 h. Additionally, assessment of outgrowths
generated from these blastocysts showed that the perturbing
conditions of a simplemedium had lasting effects on the gene
expression of the outgrowths, with altered gene expression of
Atrx and Nanog.
Human embryos donated for hESC derivation are likely
to have been exposed to conditions such as simple style
culture medium, examples of which include HTF, Earle’s, and
T6, which were widely used in IVF and can still be found
in use. Collectively, the findings of [1] therefore indicate that
these embryos are likely to have a reduced capacity to give
rise to hESCs.This in turn suggests that the characteristics of
hESC lines could be affected by predonation embryo culture
conditions.
As many human embryos, historically and presently, are
cryopreserved at the cleavage stage [20–22] and therefore
donated for ESC generation at this stage, theymust be further
cultured to the blastocyst stage before ESC derivation. This
additional culture period represents a window where the
pluripotency of embryoswhich have previously been exposed
to perturbing culture conditions can be improved.The results
of [1] demonstrated that while the quality of mouse embryos
could be improved by culturing them in modern complex
medium purpose designed to support embryo development
from the 8-cell stage, additional interventions are necessary
to fully exploit the cleavage to blastocyst culture period.
3. Insulin Stimulation of Pluripotency in
Postcompaction Embryos
The inclusion of select growth factors in embryo culture
media has previously been shown to be capable of improving
embryo development and viability [5, 23]. However, growth
factors are not routinely included in culture media com-
mercially available for human embryo culture [24–28]. To
further examine how interventions to the culture medium
for the postcompaction stage embryo may affect epiblast
cells and pluripotency, the growth factor insulin was added
to the culture medium. Insulin has previously been shown
to increase the ICM cell number of embryos [29] and was
selected as the most promising candidate from a panel of
growth factors previously used to improve embryo culture.
The findings of [7] demonstrated that 1.7𝜌M insulin
increased epiblast cell number without affecting ICM cell
number. This resulted in a significant increase in the pro-
portion of ICM cells which were epiblast as opposed to
primitive endoderm.This novel finding suggested that insulin
was acting to shift the balance of differentiation within the
ICM towards more pluripotent cells, rather than acting as a
general mitogenic factor and stimulating overall cell growth.
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This was further highlighted by the finding that total cell
number and trophectoderm cell number were also unaffected
by the addition of insulin. However, as in previous studies
[5, 23], there was a threshold concentration where the effect
of insulin was maximal, above which further increases led to
the loss of the increase in epiblast cell number. If this strategy
is implemented in the human, it may be necessary to repeat
these dose response experiments to establish an optimal dose
in terms of epiblast cell number increases. While this work
shows that insulin is able to maintain pluripotency in the
ICM and direct differentiation, other growth factors may also
have beneficial effects, and it is possible that a combination of
growth factors may produce a synergistic effect and improve
blastocyst quality and epiblast cell number.
4. Molecular Mechanism of Action of Insulin
on Pluripotency in the Blastocyst
Having demonstrated that the culture of postcompaction
stage embryos with insulin increases epiblast cell number,
further experiments were undertaken to determine the sig-
nalling pathways behind this effect [7]. At the concentration
identified as increasing epiblast cell number and proportion,
insulin is known to activate the insulin receptor [29]. One
of the primary second messengers of the insulin receptor
is PI3K, which has previously been shown to be integral
for maintaining pluripotency in ESCs [30]. Using inhibitors,
it was demonstrated that PI3K activity was necessary for
insulin to increase epiblast cell number (Figure 1). One
target of PI3K is GSK3, which is phosphorylated by active
PI3K, inactivating it. When active, GSK3 is capable of
phosphorylating many second messengers which converge
to reduce Nanog transcription, which is important for the
retention of pluripotency [31–37]. Inhibiting GSK3, theo-
retically reproducing the effect of culture with insulin and
active PI3K, increased epiblast cell number. Furthermore,
activating GSK3 blocked insulin’s ability to increase epiblast
cell number without affecting the epiblast cell number of
embryos cultured without insulin, replicating the effect of
PI3K inhibition. These results suggest that the inactivation
of GSK3 is an important component of the insulin signalling
pathway in relation to increasing epiblast cell number.
The pro-apoptotic protein p53, which is also regulated
by PI3K, specifically via PI3K activated ubiquitinase MDM2
[38–40], causes cell death and differentiationwhen active and
binds to the Nanog promoter region to repress Nanog tran-
scription [41]. As with GSK3, inhibition of p53 increased epi-
blast cell number, while activation blocked insulin-mediated
epiblast increases, strongly suggesting that p53 is involved in
insulin-mediated increases to epiblast cell number. Interest-
ingly, there are multiple points of cross-reactivity between
GSK3 and p53 [42–46]; however, no additional epiblast
increases were found for co-inhibition of the two factors.This
suggests that the potential of GSK3 inhibition to cause the
accumulation of p53 [45, 46] did not have a confounding
effect in these experiments. In conclusion, the results of
these studies demonstrated that insulin increased the epiblast
cell number via the activation of PI3K (most likely via its
interaction with the insulin receptor), which subsequently
inactivates the second messengers GSK3 and p53, to increase
Nanog transcription and therefore promote pluripotency and
the epiblast (Figure 1).
5. Expression of OCT4 and Nanog in
Blastocysts
The localisation of OCT4 and Nanog in blastocysts on
day 4 (early blastocysts), day 5 (predominantly expanded
blastocyst), and day 6 (hatching blastocysts) was determined
by immunohistochemistry [4]. Of note, it was found that
at the stage of development where the literature sources
suggested that OCT4 and Nanog would be restricted to the
ICM and epiblast, respectively [47, 48], both were still widely
expressed. A comparison of methodologies suggested that
this difference is likely the result of collecting and beginning
embryo culture at the zygote stage in this study, rather than
at the 2-cell stage or later.
Human embryos are ubiquitously cultured from the
zygote stage following in vitro fertilisation. As such, this
finding suggests that future researchers who use the mouse
blastocyst to model the in vitro development of human
embryos should culture embryos from the zygote stage, as
the discrepancy appears to produce a meaningful difference
particularly with regards to epiblast development. Future
work in this area should include the direct comparison of
OCT4 and Nanog expression of in vitro and in vivo grown
mouse embryos as well as the characterisation of Oct4 and
Nanog expression in human blastocysts.
6. Effect of Insulin in Embryo Culture Medium
Persists in Outgrowths
Despite the increase in Nanog positive cell number due to
culture with insulin, we found that when blastocysts were
plated before the transcription factor was restricted to the
epiblast, outgrowths from insulin-treated embryos contained
nomore epiblast cells than outgrowths from control embryos.
Further, our results showed that despite earlier stage blasto-
cysts possessing more OCT4 and Nanog positive cells than
later stage blastocysts, they gave rise to outgrowths with
significantly fewer epiblast cells. As hESCs have been shown
to be most efficiently derived from blastocyst where Oct4
has been restricted to the ICM [49], this finding supports
the use of mouse blastocysts in modelling human embryo
development and hESC derivation. The important finding
from these experiments, however, was that when embryos
were allowed to develop until Nanog was restricted to the
epiblast and OCT4 was restricted to the ICM before plating,
culture of embryos in insulin postcompaction resulted in the
generation of outgrowths which were more likely to contain
an epiblast and which contained a larger number of epiblast
cells.

























Figure 1: Schematic of insulin signalling and its regulation of Nanog expression and pluripotency. Green arrows indicate reactions with
a stimulatory effect on their target, and red closed bars indicate reactions with a retarding effect on their target. P marks reactions where
phosphorylation occurs, and Ub marks reactions where ubiquitination occurs. Insulin binds the insulin receptor (IR), a tyrosine kinase
which is then able to phosphorylate the IRSs. PI3K is able to bind to the phosphorylated IRSs by its SH2 domains, resulting in activation. PI3K
phosphorylates the phospholipid PIP2, producing PIP3, which can be bound by the pleckstrin homology domains of PDK-1 and Akt. Results
in [7] show that activation of PI3K is necessary for insulin to increase the number of Nanog positive epiblast cells during embryo culture.
When PDK-1 and Akt are colocalised to the cell membrane, PDK-1 is able to phosphorylate and activate Akt. Active Akt can phosphorylate
GSK3, inactivating it. When active, GSK3 is able to phosphorylate 𝛽-catenin, Hedgehog, and c-Myc; all factors which safeguard pluripotency
through interactions with other secondmessengers. Additionally, active GSK3 phosphorylates and protects the intracellular domain of Notch,
promoting differentiation. Further, inactivation of GSK3 is necessary for insulin to increase the number of Nanog positive epiblast cells
during embryo culture [7]. Akt is also able to phosphorylate and activate MDM2 which ubiquitinates the proapoptotic factor p53, causing
its inactivation and removal from the nucleus, where it would bind to the Nanog promoter and suppresses its expression. Inactivation of p53
is necessary for insulin to increase the number of Nanog positive epiblast cells during embryo culture [7]. GSK3 and p53 are able to form
a dimer, resulting in the phosphorylation of p53 and the increased activity of both factors. GSK3 is also able to phosphorylate and activate
MDM2. However, despite these outcomes, the interaction of GSK3 and p53 do not have a significant effect on Nanog positive epiblast cell
number during embryo culture [7].











Effect on quality 
for ESC generation
Embryonic stem cell derivation and embryo culture
Figure 2: Summary of the culture effects examined in this paper and their observed effect on the retention of pluripotency towards ESC
derivation.
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7. Insulin in Culture Media and the Effect of
ESC Colony Generation
Insulin- and control-treated blastocysts were plated on day
6, outgrown, trypsinised, and replated, and primary cell
colonieswith an ESCmorphologywere stained forOCT4 and
Nanog expression to confirm pluripotency [4]. Blastocysts
were twice as likely to give rise to primary ESC colonies
if they were cultured with insulin for the postcompaction
stage. Interestingly, examining how the inclusion of insulin
interacted with this process led to the novel observation that
culture of embryos with insulin increased the proportion of
embryos which, at the point of plating, were at the most
advanced morphological stage (hatched) and also increased
the proportion of those hatched blastocysts which gave rise to
ESCs. As such, hatched insulin-cultured blastocysts are more
plentiful and more likely to give rise to ESCs than hatched
control-cultured blastocysts. This result demonstrates that
insulin improves ESC isolation through mechanisms beyond
simply improving morphology, which has previously been
linked to increased ESC derivation rates. It is likely that the
improved capacity of insulin-cultured blastocysts with the
highest morphological quality to give rise to primary ESC
colonies is the result of the increased epiblast cell numbers
demonstrated in both [4, 7].
Modelling of the experimental outcomes enabled conclu-
sions to be made around the most significant characteristics
that an embryo must contain to generate a primary ESC
colony.The greatest predictor of a control-cultured blastocyst
giving rise to a primary ESC colony was it cavitating on
day 4, whereas for blastocysts cultured with insulin, the
greatest predictor was being hatched on day 6. For day 4, this
observation is likely the result of insulin increasing the rate
of cavitation and thereby making the marker less selective.
The finding on day 6 is suggestive that in the control group,
hatched blastocysts, which have shown the best development,
have nomore epiblast cells than their more slowly developing
counterparts. Both of these observations warrant further
investigation.
The results of this work demonstrate that the addition of
insulin to embryo culture medium from the cleavage stage to
the blastocyst stage improves the efficiency with which ESCs
can be generated from these embryos. As human embryos are
most often donated at the cleavage stage and ESC derivation
ismost often attempted at the blastocyst stage, the application
of this strategy has the potential to improve hESC derivation
efficiency. Due to the limited availability of human embryos
for ESC derivation, improving efficiency is a matter of key
importance.
Future work which would be necessary to validate these
findings is the expansion of mESC colonies from control-
and insulin-cultured embryos to fully characterised mESC
lines and the reproduction of these experiments in the
human. Further, our work has shown that the effect of insulin
persists beyond embryo culture through the outgrowth phase
and into ESC derivation. This suggests that during embryo
culture-insulin may have a permanent positive effect on
cell properties and that ESC lines derived from embryos
cultured with insulin may have altered characteristics. As
such, future work should include not just the characterisation
of ESC lines from control and insulin-cultured embryos
for pluripotency and self-renewal, but also more in depth
characterisation including metabolic profile, an assessment
of DNA methylation and acetylation, and gene expression,
to provide a more detailed and precise picture of the quality
and differentiation status of ESC lines, with a view towards
investigating whether the culture of embryos with insulin
results in the derivation of higher quality ESC lines.
8. Conclusion
In conclusion, the results presented in this paper show
that while culture in simple medium during the cleavage
stage decreases pluripotency, the inclusion of insulin in
embryo culture medium from the compaction stage stim-
ulates pluripotency supporting pathways to increase the
number of epiblast cells in the fully developed blastocyst,
resulting in an increased capacity to generate ESCs (Figure 2).
This strategy is of particular relevance for hESC derivation
where embryos are most often donated at the cleavage stage
and of reduced quality.
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